Email
IZ Express #1,819: FDA approves RSV antibody and expands age range for mResvia RSV vaccine, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,819: FDA approves RSV antibody and expands age range for mResvia RSV vaccine, and more |
| Date | June 18, 2025 10:02 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,819: June 18, 2025
Top Stories
* FDA approves clesrovimab (Enflonsia, Merck), a long-acting RSV preventive antibody for infants up to age 12 months during or entering their first RSV season (#IZX1)
* FDA expands license for mResvia (RSV vaccine, Moderna) to include high-risk adults age 18 to 59 years (#IZX2)
* Stanford and Emory Universities create the WastewaterSCAN Dashboard to show trends in infectious diseases, including measles, in certain localities (#IZX3)
* Medical professional societies react to recent changes in ACIP membership (#IZX4)
* Confirmed measles cases increase to 1,197 across 34 states; Arizona reports its first 2025 cases (#IZX5)
* Immunize.org's Influenza Vaccination Honor Roll for healthcare worker vaccination requirements welcomes a new facility (#IZX6)
* "How Does PCV7 Receipt Factor into Decisions About Adult Pneumococcal Vaccination?” Watch the 1-minute synopsis, part of the Ask the Experts Video Series on YouTube (#IZX7)
* Vaccines in the news (#IZX8)
Immunize.org Website and Clinical Resources
* Spotlight on the website: Ask the Experts section now allows you to copy a link to your clipboard (#IZX9)
* Recap: Immunize.org updates “Vaccine Administration Record for Children and Teens” and “Vaccine Administration Record for Adults” (#IZX10)
* Recap: Immunize.org updates references in two more standing orders templates (#IZX11)
* Recap: Immunize.org updates its "Notification of Immunization Letter Template" (#IZX12)
Featured Resources
* American Academy of Pediatrics releases four free on-demand Red Book webinars focused on measles (#IZX13)
* Use CDC and Immunize.org’s resources to prepare travelers for domestic and international trips (#IZX14)
* Keep the 2025 immunization schedule at your fingertips! Order laminated 2025 U.S. adult immunization schedule booklets from Immunize.org. (#IZX15)
* Need to teach vaccine administration? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download (#IZX16)
Notable Publications
* “Measles in Pregnancy” published in Canadian Medical Association Journal (#IZX17)
Upcoming Events
* Today, virtual: NFID hosts webinar titled “Protecting Patients Before Travel” on June 18 at 1:00 p.m. (ET) (#IZX18)
* Virtual: Association of Immunization Managers hosts webinar titled “Correlation and Causation: Understanding and Debunking Claims Linking Vaccines and Autism” on June 24 at 2:00 p.m. (ET) (#IZX19)
* Virtual: Public Health Communications Collaborative hosts webinar titled "Building Your Public Health Comms Toolkit: Communications Planning on a Budget" on June 25 at 3:30 p.m. (ET) (#IZX19)
* Virtual: HPV Vaccine Acceleration Program Partners Initiative Consortium hosts webinar titled “Expanding Reach: Insights from Multi-Country Approaches to HPV Vaccination for Out-of-School Girls” on June 25 at 9:00 a.m. (ET) (#IZX20)
* Virtual: Watch upcoming June 25–27 ACIP meeting with discussion of several vaccine recommendations, including COVID-19, HPV, influenza, meningococcal, and RSV (#IZX22)
* Virtual: New Jersey Chapter of American Academy of Pediatrics hosts webinar, “From Inoculation to Innovation: The Historical and Ethical Journey of Vaccination,” on June 30 at 3:00 p.m. (ET) (#IZX23)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
FDA approves clesrovimab (Enflonsia, Merck), a long-acting RSV preventive antibody for infants up to age 12 months during or entering their first RSV season
On June 9, FDA approved a second long-acting RSV preventive antibody, clesrovimab-cfor (Enflonsia, Merck) ([link removed]) . It is indicated for the prevention of RSV lower respiratory tract disease in neonates and infants up to age 12 months who are born during or entering their first RSV season.
Related Links
* FDA: Enflonsia package insert ([link removed]) (PDF)
* FDA: Novel Drug Approvals for 2025 ([link removed]) web page
* Immunize.org: Package Inserts and FDA Product Approvals ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
FDA expands license for mResvia (RSV vaccine, Moderna) to include high-risk adults age 18 to 59 years
On June 12, FDA expanded the indicated age range for mResvia (RSV vaccine, Moderna) ([link removed]) . Previously, mResvia was indicated for the prevention of lower respiratory tract disease (LRTD) caused by RSV solely in those age 60 years and older. This approval expands the indication to include adults age 18 through 59 years who are at increased risk for LRTD due to RSV.
Related Links
* FDA: mResvia ([link removed]) web page
* FDA: mResvia package insert ([link removed]) (PDF)
* FDA: Novel Drug Approvals for 2025 ([link removed]) web page
* Immunize.org: Package Inserts and FDA Product Approvals ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Stanford and Emory Universities create the WastewaterSCAN Dashboard to show trends in infectious diseases, including measles, in certain localities
Studying wastewater can help health departments track and prevent disease from circulating in the community. Stanford University, in partnership with Emory University, developed WastewaterSCAN ([link removed]) to monitor infectious diseases through municipal wastewater systems to inform public health responses at a local, regional, and national level. The information can be viewed on the WastewaterSCAN Dashboard ([link removed]) web page.
WastewaterSCAN shares methods and data with the CDC National Wastewater Surveillance System ([link removed]) (NWSS) program. NWSS works with partners to test and monitor wastewater for viruses and bacteria so communities can act quickly to prevent the spread of infections.
[link removed]
Pathogens tracked with this project include Candida auris, enterovirus D68, hepatitis A, human metapneumovirus, influenza A, influenza B, measles, mpox clade Ib, mpox clade II, norovirus, RSV, and SARS-CoV-2.
View the WastewaterSCAN Dashboard ([link removed]) .
Related Links
* WastewaterSCAN website ([link removed])
* WastewaterSCAN Dashboard ([link removed]) web page
* CDC: National Wastewater Surveillance System ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Medical professional societies react to recent changes in ACIP membership
NFID ([link removed]) posted a compilation of statements ([link removed]) from medical, pharmacy, nursing, public health, and other professional and community associations describing the crucial role ACIP played in the United States since the 1960s. NFID will update this collection as it learns of additional partner statements.
Back to top (#Top)
------------------------------------------------------------
Confirmed measles cases increase to 1,197 across 34 states; Arizona reports its first 2025 cases
As of June 12, CDC reported 1,197 confirmed measles cases ([link removed]) in 2025 in 34 states, including the first cases reported this year in Arizona. The states with the most confirmed cases in 2025 are Texas (777, 64.9%) ([link removed]) and New Mexico (81, 6.7%) ([link removed]) . Among confirmed cases, 12% were hospitalized, with 29% younger than age 5 years.
CDC only requires reporting of laboratory-confirmed measles cases. Cases without laboratory testing for confirmation are not included in these numbers. Actual numbers of cases are, therefore, higher than confirmed case counts.
A map of 2025 measles cases ([link removed]) in the contiguous United States, as of June 10, from the Johns Hopkins International Vaccine Access Center ([link removed]) appears below. The U.S. Measles Tracker ([link removed]) website includes state and county-level data.
[link removed]
CDC updated its Travelers' Health: Global Measles ([link removed]) web page to encourage all international travelers to be fully vaccinated before travel. Additionally, CDC offers resources for communities experiencing a measles outbreak including infographics for families, images to help clinic personnel identify cases, guidance for caring for patients with measles ([link removed]) , and a Be Ready for Measles communication toolkit ([link removed]) . Spanish-language resources ([link removed]) are now available on the toolkit page.
[link removed]
Related Links
* CDC: Measles Cases and Outbreaks ([link removed]) main page
* CDC: Be Ready for Measles Toolkit ([link removed])
* Center for Outbreak Response Innovation: Measles Outbreak Response ([link removed]) main page
* Immunize.org: Vaccines A–Z: Measles ([link removed]) main page
* Immunize.org: Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Children and Teens ([link removed]) (PDF)
* Immunize.org: Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Adults ([link removed]) (PDF)
* Immunize.org: Ask the Experts: MMR (Measles, Mumps, and Rubella) ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Immunize.org's Influenza Vaccination Honor Roll for healthcare worker vaccination requirements welcomes a new facility
Immunize.org's Influenza Vaccination Honor Roll ([link removed]) recognizes facilities that take a stand for patient safety by implementing policies requiring vaccination for healthcare personnel. Immunize.org welcomes Jefferson Healthcare – Port Townsend, Port Townsend, WA, to our honor roll.
[link removed]
Eligibility
* Eligible organizations: hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
* Requirements:
+ Your policy must require influenza vaccination for all staff
+ The application ([link removed]) must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire shift)
Related Links
* Immunize.org: Honor Roll Honorees: Influenza ([link removed])
* About the Influenza Vaccination Honor Roll ([link removed])
Back to top (#Top)
------------------------------------------------------------
"How Does PCV7 Receipt Factor into Decisions About Adult Pneumococcal Vaccination?” Watch the 1-minute synopsis, part of the Ask the Experts Video Series on YouTube
This week, our featured episode from the Ask the Experts Video Series is titled How Does PCV7 Receipt Factor into Decisions About Adult Pneumococcal Vaccination? ([link removed] ) The video describes CDC's recommendation that, when calculating the number of prior pneumococcal doses, any PCV7 doses be disregarded.
The 1-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
[link removed]
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* CBC: 6 Infants Born with Congenital Measles from Unvaccinated Mothers in Ontario Since Last Fall ([link removed]) (6/9/25)
* CIDRAP: Studies Show Safety, Low Side-Effect Profile of COVID Vaccines in Pregnancy ([link removed]) (6/9/25)
* Science: NIH Terminates Network Aimed at Stopping Pandemics Before They Start ([link removed]) (6/9/25)
* ABC: US Measles Cases Nearing 30-Year High ([link removed]) (6/6/25)
* Politico: WHO Sounds the Alarm as US Measles Cases Mount ([link removed]) (6/6/25)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: Ask the Experts section now allows you to copy a link to your clipboard
This week’s Spotlight features an enhancement to our popular Ask the Experts ([link removed]) question and answer section. You can now copy a link for a question and its answer to your clipboard. This applies both when viewing search results and when browsing questions by topic.
When viewing a list of questions, there is now a link icon (🔗) on the right of each question banner, next to the show/hide caret (⌄). Selecting the link icon will copy the corresponding hyperlink for that one question and answer to your clipboard. A “link copied” message will briefly be displayed.
You can paste this link into a web browser to view that question as a separate web page. Also, the link can be shared by pasting it in an email, document, or on social media. We hope this enhancement makes it easier to save and share the practical answers Ask the Experts provides about vaccines and vaccine administration.
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates “Vaccine Administration Record for Children and Teens” and “Vaccine Administration Record for Adults”
Immunize.org updated vaccine administration records for children and teens ([link removed]) and for adults ([link removed]) , adding Penmenvy (MenABCWY, GSK), which FDA licensed on February 14, 2025. ACIP voted on recommendations for its use at the April meeting; these recommendations are pending acceptance by the CDC Director or Secretary of Health and Human Services.
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates references in two more standing orders templates
Immunize.org continues to update its standing orders templates ([link removed]) to remove the reference to the excipient table that used to appear in Appendix B ([link removed]) of the Epidemiology and Prevention of Vaccine-Preventable Diseases (the "Pink Book"). The two updated standing order templates posted most recently are:
* Standing Orders for Administering Meningococcal ACWY Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Meningococcal ACWY Vaccine to Adults ([link removed])
Previously announced updated standing orders templates include:
* Standing Orders for Administering Rotavirus Vaccine to Infants ([link removed])
* Standing Orders for Administering Human Papillomavirus Vaccine to Children and Teens ([link removed]) (additional update to font and QR code)
* Standing Orders for Administering Human Papillomavirus Vaccine to Adults ([link removed])
* Standing Orders for Administering Hepatitis A Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Hepatitis A Vaccine to Adults ([link removed])
* Standing Orders for Administering Varicella Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Varicella Vaccine to Adults ([link removed])
* Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Adults ([link removed])
* Standing Orders for Administering Pneumococcal Vaccines to Children and Teens ([link removed])
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates its "Notification of Immunization Letter Template"
Immunize.org updated its Notification of Immunization Letter Template ([link removed]) , adding Penmenvy (MenABCWY, GSK), which FDA licensed on February 14, 2025. ACIP voted on recommendations for its use at the April meeting; these recommendations are pending acceptance by the CDC Director or Secretary of Health and Human Services.
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
American Academy of Pediatrics releases four free on-demand Red Book webinars focused on measles
The American Academy of Pediatrics ([link removed]) released four free Red Book Online Webinars ([link removed]) focused on measles, including:
* Spotting a Threat: Measles in Immunocompromised Children (24:40)
* Infection Prevention & Control for Measles (14:56)
* The Use of Vitamin A in the Management of Measles (5:35)
* Identifying and Diagnosing Measles in the Pediatric Setting (two parts: 5:21, 9:44)
[link removed]
Earlier in 2025, the webinar series focused on “Mpox Basics.”
View the webinars ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Use CDC and Immunize.org’s resources to prepare travelers for domestic and international trips
To help with safe travel planning, use these three sets of travel resources.
Visit CDC's Travelers' Health ([link removed]) website to view information on more than 50 topics to help in deciding what vaccines, medications, and other measures are needed to prevent illness during travel.
[link removed]
CDC's Travelers' Health: Traveler Advice ([link removed]) web page includes information grouped by reasons for travel, travelers with special considerations, general tips, tips during travel, and tips after travel.
[link removed]
Immunize.org's Travel Vaccines main page ([link removed]) makes it easy to access current travel vaccination guidance from authoritative sources. It offers direct links to popular CDC and nongovernment resources.
The U.S. State Department allows travelers to register their itinerary and receive emergency messages via the Smart Traveler Enrollment Program ([link removed]) .
[link removed]
Related Links
* CDC: Travelers' Health ([link removed]) web page
* CDC: Travelers' Health: Traveler Advice ([link removed]) web page
* CDC Yellow Book: Health Information for International Travel ([link removed])
* Immunize.org: Travel Vaccines ([link removed]) main page
* U.S. Department of State: Smart Traveler Enrollment Program ([link removed])
Back to top (#Top)
------------------------------------------------------------
Keep the 2025 immunization schedule at your fingertips! Order laminated 2025 U.S. adult immunization schedule booklets from Immunize.org.
Laminated booklets of the 2025 U.S. adult immunization schedule ([link removed]) are available in the Immunize.org shop. The 2025 child and adolescent schedule booklets sold out.
The schedules are available online as PDFs from CDC ([link removed]) at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given.
[link removed]
Adult Booklets
1 copy: $10.00
2–4 copies: $9.50 each
5–19 copies: $8.50 each
20–99 copies: $7.50 each
100–499 copies: $6.00 each
500–999 copies: $5.00 each
1,000–1,999 copies: $4.00 each
2,000+ copies: $3.25 each
Visit the Shop Immunize.org: Laminated Schedules ([link removed]) web page to view images and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Need to teach vaccine administration? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download
Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide ([link removed]) is available to download/print either by chapter or in its entirety free of charge. The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s Clinical Resources on adult immunization ([link removed])
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Measles in Pregnancy” published in Canadian Medical Association Journal
In the June 9 issue, the Canadian Medical Association Journal published Measles in Pregnancy ([link removed]) , a practice summary. The authors briefly explain five key points:
* Measles in pregnancy poses serious maternal and fetal risks
* Intravenous immunoglobulin (IVIG) can reduce the risk of infection or lessen the severity of measles during exposed, susceptible pregnancies
* Special care considerations are necessary for people admitted to hospital with measles, given its airborne transmission and high infectivity
* Maternal infection in the 2 weeks before delivery can lead to severe congenital infection
* Ensuring everyone of reproductive age is up to date with measles vaccination is crucial to prevent complications during pregnancy and after delivery
An accompanying editorial, Pregnant and Bearing the Burden of Measles Outbreaks in Canada ([link removed]) , points out:
Even in well-resourced settings, measles has devastating consequences. During an outbreak in Italy in 2017, researchers followed 24 pregnant women with measles infections, among whom were 6 (25.0%) premature deliveries; 4 (16.7%) miscarriages and fetal deaths; and 20 (80.0%) maternal hospitalizations from complications related to measles, most frequently pneumonia.
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today, virtual: NFID hosts webinar titled “Protecting Patients Before Travel” on June 18 at 1:00 p.m. (ET)
NFID ([link removed]) will host a webinar titled Protecting Patients Before Travel ([link removed] ) at 1:00 p.m. (ET) on June 18. The panel includes NFID Medical Director Robert H. Hopkins Jr., MD; Chapman University School of Pharmacy Professor Jeffery A. Goad, PharmD, MPH; and Harvard Medical School Associate Professor Lin H. Chen, MD. Speakers will review current recommendations for travelers and share implementation strategies.
CME and CNE credit are available. There is no fee to participate in this activity, but preregistration is required.
Register for the webinar ([link removed]) .
[link removed]
NFID hosts monthly webinars ([link removed]) to increase awareness of the importance of infectious disease prevention and treatment. CME, CNE, and CPE credits are available for select recordings. View all archived NFID webinars ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: Association of Immunization Managers hosts webinar titled “Correlation and Causation: Understanding and Debunking Claims Linking Vaccines and Autism” on June 24 at 2:00 p.m. (ET)
The Association of Immunization Managers (AIM) will host a webinar titled Correlation and Causation: Understanding and Debunking Claims Linking Vaccines and Autism ([link removed]) at 2:00 p.m. (ET) on June 24. Michelle Fiscus, MD, FAAP, AIM’s chief medical officer, will give an overview of autism spectrum disorder and how the vaccine-autism claim emerged and persists. Dr. Fiscus will summarize key studies that debunked the claim and share communication tools for immunization programs and healthcare providers to engage families and communities in informed conversations.
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: Public Health Communications Collaborative hosts webinar titled "Building Your Public Health Comms Toolkit: Communications Planning on a Budget" on June 25 at 3:30 p.m. (ET)
The Public Health Communications Collaborative (PHCC) will host a webinar titled Building Your Public Health Comms Toolkit: Communications Planning on a Budget ([link removed]) at 3:30 p.m. (ET) on June 25. During this webinar, public health and communications experts will provide tools, tips, and stories that support effective public health campaigns on small or nonexistent budgets. Attendees will learn more about:
* Building a free or low-cost toolkit for content planning, organization, and distribution of key public health messages
* How new partnership approaches can amplify your messages where people need to hear them
* Free or low-cost communication channels that can provide clarity, connection, and better community health outcomes
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: HPV Vaccine Acceleration Program Partners Initiative Consortium hosts webinar titled “Expanding Reach: Insights from Multi-Country Approaches to HPV Vaccination for Out-of-School Girls” on June 25 at 9:00 a.m. (ET)
The HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium ([link removed]) will host a webinar titled Expanding Reach: Insights from Multi-Country Approaches to HPV Vaccination for Out-of-School Girls ([link removed]) at 9:00 a.m. (ET) on June 25. During the webinar, learn how programs are reaching girls missed by school-based HPV vaccination efforts. The webinar will explore five themes: characterization of out-of-school girls; how programs identify such girls; program coordination; community awareness and demand generation; and delivery strategies.
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: Watch upcoming June 25–27 ACIP meeting with discussion of several vaccine recommendations, including COVID-19, HPV, influenza, meningococcal, and RSV
CDC is scheduled to convene the ACIP ([link removed]) on June 25–27. Recommendation votes are scheduled for COVID-19, HPV, influenza, meningococcal, and RSV vaccines. Additionally, the agenda includes discussion of vaccines targeting anthrax, chikungunya, cytomegalovirus (CMV), Lyme, and pneumococcal diseases.
After dismissing 17 members of ACIP ([link removed]) , HHS announced eight new members ([link removed]) .
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for written or oral public comment are described on the website ([link removed]) .
View meeting information ([link removed]) .
[link removed]
Related Links
* CDC: ACIP main page ([link removed]) for access to webcast, agendas
* CDC: ACIP: Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
View the agenda ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: New Jersey Chapter of American Academy of Pediatrics hosts webinar, “From Inoculation to Innovation: The Historical and Ethical Journey of Vaccination,” on June 30 at 3:00 p.m. (ET)
The New Jersey Chapter of American Academy of Pediatrics (AAP) will host a webinar titled From Inoculation to Innovation: The Historical and Ethical Journey of Vaccination ([link removed] ) at 3:00 p.m. (ET) on June 30. The speakers will be David J. Cennimo, MD, FACP, Associate Professor of Medicine and Pediatric Infectious Disease, Rutgers University, and Luis Alzate-Duque, MD, MPH, Assistant Professor of Medicine and Pediatrics, Rutgers New Jersey Medical School. Learning objectives include:
* Exploring the historical milestones in vaccine development from early inoculation to modern immunization strategies
* Understanding the impact of vaccines on global health outcomes and economic savings, especially in childhood mortality and disease prevention
* Examining historical and ongoing opposition to vaccines, exploring the roots of vaccine hesitancy and organized anti-vaccination movements
* Discussing the ethical challenges related to vaccine mandates, informed consent, research practices, and global equity
* Evaluating the public health implications of vaccine acceptance and refusal, using predictive modeling and real-world case studies
Register for the webinar ([link removed] ) .
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Gr
äbenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,819: June 18, 2025
Top Stories
* FDA approves clesrovimab (Enflonsia, Merck), a long-acting RSV preventive antibody for infants up to age 12 months during or entering their first RSV season (#IZX1)
* FDA expands license for mResvia (RSV vaccine, Moderna) to include high-risk adults age 18 to 59 years (#IZX2)
* Stanford and Emory Universities create the WastewaterSCAN Dashboard to show trends in infectious diseases, including measles, in certain localities (#IZX3)
* Medical professional societies react to recent changes in ACIP membership (#IZX4)
* Confirmed measles cases increase to 1,197 across 34 states; Arizona reports its first 2025 cases (#IZX5)
* Immunize.org's Influenza Vaccination Honor Roll for healthcare worker vaccination requirements welcomes a new facility (#IZX6)
* "How Does PCV7 Receipt Factor into Decisions About Adult Pneumococcal Vaccination?” Watch the 1-minute synopsis, part of the Ask the Experts Video Series on YouTube (#IZX7)
* Vaccines in the news (#IZX8)
Immunize.org Website and Clinical Resources
* Spotlight on the website: Ask the Experts section now allows you to copy a link to your clipboard (#IZX9)
* Recap: Immunize.org updates “Vaccine Administration Record for Children and Teens” and “Vaccine Administration Record for Adults” (#IZX10)
* Recap: Immunize.org updates references in two more standing orders templates (#IZX11)
* Recap: Immunize.org updates its "Notification of Immunization Letter Template" (#IZX12)
Featured Resources
* American Academy of Pediatrics releases four free on-demand Red Book webinars focused on measles (#IZX13)
* Use CDC and Immunize.org’s resources to prepare travelers for domestic and international trips (#IZX14)
* Keep the 2025 immunization schedule at your fingertips! Order laminated 2025 U.S. adult immunization schedule booklets from Immunize.org. (#IZX15)
* Need to teach vaccine administration? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download (#IZX16)
Notable Publications
* “Measles in Pregnancy” published in Canadian Medical Association Journal (#IZX17)
Upcoming Events
* Today, virtual: NFID hosts webinar titled “Protecting Patients Before Travel” on June 18 at 1:00 p.m. (ET) (#IZX18)
* Virtual: Association of Immunization Managers hosts webinar titled “Correlation and Causation: Understanding and Debunking Claims Linking Vaccines and Autism” on June 24 at 2:00 p.m. (ET) (#IZX19)
* Virtual: Public Health Communications Collaborative hosts webinar titled "Building Your Public Health Comms Toolkit: Communications Planning on a Budget" on June 25 at 3:30 p.m. (ET) (#IZX19)
* Virtual: HPV Vaccine Acceleration Program Partners Initiative Consortium hosts webinar titled “Expanding Reach: Insights from Multi-Country Approaches to HPV Vaccination for Out-of-School Girls” on June 25 at 9:00 a.m. (ET) (#IZX20)
* Virtual: Watch upcoming June 25–27 ACIP meeting with discussion of several vaccine recommendations, including COVID-19, HPV, influenza, meningococcal, and RSV (#IZX22)
* Virtual: New Jersey Chapter of American Academy of Pediatrics hosts webinar, “From Inoculation to Innovation: The Historical and Ethical Journey of Vaccination,” on June 30 at 3:00 p.m. (ET) (#IZX23)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
FDA approves clesrovimab (Enflonsia, Merck), a long-acting RSV preventive antibody for infants up to age 12 months during or entering their first RSV season
On June 9, FDA approved a second long-acting RSV preventive antibody, clesrovimab-cfor (Enflonsia, Merck) ([link removed]) . It is indicated for the prevention of RSV lower respiratory tract disease in neonates and infants up to age 12 months who are born during or entering their first RSV season.
Related Links
* FDA: Enflonsia package insert ([link removed]) (PDF)
* FDA: Novel Drug Approvals for 2025 ([link removed]) web page
* Immunize.org: Package Inserts and FDA Product Approvals ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
FDA expands license for mResvia (RSV vaccine, Moderna) to include high-risk adults age 18 to 59 years
On June 12, FDA expanded the indicated age range for mResvia (RSV vaccine, Moderna) ([link removed]) . Previously, mResvia was indicated for the prevention of lower respiratory tract disease (LRTD) caused by RSV solely in those age 60 years and older. This approval expands the indication to include adults age 18 through 59 years who are at increased risk for LRTD due to RSV.
Related Links
* FDA: mResvia ([link removed]) web page
* FDA: mResvia package insert ([link removed]) (PDF)
* FDA: Novel Drug Approvals for 2025 ([link removed]) web page
* Immunize.org: Package Inserts and FDA Product Approvals ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Stanford and Emory Universities create the WastewaterSCAN Dashboard to show trends in infectious diseases, including measles, in certain localities
Studying wastewater can help health departments track and prevent disease from circulating in the community. Stanford University, in partnership with Emory University, developed WastewaterSCAN ([link removed]) to monitor infectious diseases through municipal wastewater systems to inform public health responses at a local, regional, and national level. The information can be viewed on the WastewaterSCAN Dashboard ([link removed]) web page.
WastewaterSCAN shares methods and data with the CDC National Wastewater Surveillance System ([link removed]) (NWSS) program. NWSS works with partners to test and monitor wastewater for viruses and bacteria so communities can act quickly to prevent the spread of infections.
[link removed]
Pathogens tracked with this project include Candida auris, enterovirus D68, hepatitis A, human metapneumovirus, influenza A, influenza B, measles, mpox clade Ib, mpox clade II, norovirus, RSV, and SARS-CoV-2.
View the WastewaterSCAN Dashboard ([link removed]) .
Related Links
* WastewaterSCAN website ([link removed])
* WastewaterSCAN Dashboard ([link removed]) web page
* CDC: National Wastewater Surveillance System ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Medical professional societies react to recent changes in ACIP membership
NFID ([link removed]) posted a compilation of statements ([link removed]) from medical, pharmacy, nursing, public health, and other professional and community associations describing the crucial role ACIP played in the United States since the 1960s. NFID will update this collection as it learns of additional partner statements.
Back to top (#Top)
------------------------------------------------------------
Confirmed measles cases increase to 1,197 across 34 states; Arizona reports its first 2025 cases
As of June 12, CDC reported 1,197 confirmed measles cases ([link removed]) in 2025 in 34 states, including the first cases reported this year in Arizona. The states with the most confirmed cases in 2025 are Texas (777, 64.9%) ([link removed]) and New Mexico (81, 6.7%) ([link removed]) . Among confirmed cases, 12% were hospitalized, with 29% younger than age 5 years.
CDC only requires reporting of laboratory-confirmed measles cases. Cases without laboratory testing for confirmation are not included in these numbers. Actual numbers of cases are, therefore, higher than confirmed case counts.
A map of 2025 measles cases ([link removed]) in the contiguous United States, as of June 10, from the Johns Hopkins International Vaccine Access Center ([link removed]) appears below. The U.S. Measles Tracker ([link removed]) website includes state and county-level data.
[link removed]
CDC updated its Travelers' Health: Global Measles ([link removed]) web page to encourage all international travelers to be fully vaccinated before travel. Additionally, CDC offers resources for communities experiencing a measles outbreak including infographics for families, images to help clinic personnel identify cases, guidance for caring for patients with measles ([link removed]) , and a Be Ready for Measles communication toolkit ([link removed]) . Spanish-language resources ([link removed]) are now available on the toolkit page.
[link removed]
Related Links
* CDC: Measles Cases and Outbreaks ([link removed]) main page
* CDC: Be Ready for Measles Toolkit ([link removed])
* Center for Outbreak Response Innovation: Measles Outbreak Response ([link removed]) main page
* Immunize.org: Vaccines A–Z: Measles ([link removed]) main page
* Immunize.org: Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Children and Teens ([link removed]) (PDF)
* Immunize.org: Standing Orders for Administering Measles, Mumps, and Rubella Vaccine to Adults ([link removed]) (PDF)
* Immunize.org: Ask the Experts: MMR (Measles, Mumps, and Rubella) ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Immunize.org's Influenza Vaccination Honor Roll for healthcare worker vaccination requirements welcomes a new facility
Immunize.org's Influenza Vaccination Honor Roll ([link removed]) recognizes facilities that take a stand for patient safety by implementing policies requiring vaccination for healthcare personnel. Immunize.org welcomes Jefferson Healthcare – Port Townsend, Port Townsend, WA, to our honor roll.
[link removed]
Eligibility
* Eligible organizations: hospitals, long-term care facilities, medical practices, pharmacies, professional organizations, health departments, and other government entities
* Requirements:
+ Your policy must require influenza vaccination for all staff
+ The application ([link removed]) must describe measures to prevent transmission of influenza from unvaccinated personnel to patients (e.g., masking for the entire shift)
Related Links
* Immunize.org: Honor Roll Honorees: Influenza ([link removed])
* About the Influenza Vaccination Honor Roll ([link removed])
Back to top (#Top)
------------------------------------------------------------
"How Does PCV7 Receipt Factor into Decisions About Adult Pneumococcal Vaccination?” Watch the 1-minute synopsis, part of the Ask the Experts Video Series on YouTube
This week, our featured episode from the Ask the Experts Video Series is titled How Does PCV7 Receipt Factor into Decisions About Adult Pneumococcal Vaccination? ([link removed] ) The video describes CDC's recommendation that, when calculating the number of prior pneumococcal doses, any PCV7 doses be disregarded.
The 1-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
[link removed]
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* CBC: 6 Infants Born with Congenital Measles from Unvaccinated Mothers in Ontario Since Last Fall ([link removed]) (6/9/25)
* CIDRAP: Studies Show Safety, Low Side-Effect Profile of COVID Vaccines in Pregnancy ([link removed]) (6/9/25)
* Science: NIH Terminates Network Aimed at Stopping Pandemics Before They Start ([link removed]) (6/9/25)
* ABC: US Measles Cases Nearing 30-Year High ([link removed]) (6/6/25)
* Politico: WHO Sounds the Alarm as US Measles Cases Mount ([link removed]) (6/6/25)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: Ask the Experts section now allows you to copy a link to your clipboard
This week’s Spotlight features an enhancement to our popular Ask the Experts ([link removed]) question and answer section. You can now copy a link for a question and its answer to your clipboard. This applies both when viewing search results and when browsing questions by topic.
When viewing a list of questions, there is now a link icon (🔗) on the right of each question banner, next to the show/hide caret (⌄). Selecting the link icon will copy the corresponding hyperlink for that one question and answer to your clipboard. A “link copied” message will briefly be displayed.
You can paste this link into a web browser to view that question as a separate web page. Also, the link can be shared by pasting it in an email, document, or on social media. We hope this enhancement makes it easier to save and share the practical answers Ask the Experts provides about vaccines and vaccine administration.
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates “Vaccine Administration Record for Children and Teens” and “Vaccine Administration Record for Adults”
Immunize.org updated vaccine administration records for children and teens ([link removed]) and for adults ([link removed]) , adding Penmenvy (MenABCWY, GSK), which FDA licensed on February 14, 2025. ACIP voted on recommendations for its use at the April meeting; these recommendations are pending acceptance by the CDC Director or Secretary of Health and Human Services.
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates references in two more standing orders templates
Immunize.org continues to update its standing orders templates ([link removed]) to remove the reference to the excipient table that used to appear in Appendix B ([link removed]) of the Epidemiology and Prevention of Vaccine-Preventable Diseases (the "Pink Book"). The two updated standing order templates posted most recently are:
* Standing Orders for Administering Meningococcal ACWY Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Meningococcal ACWY Vaccine to Adults ([link removed])
Previously announced updated standing orders templates include:
* Standing Orders for Administering Rotavirus Vaccine to Infants ([link removed])
* Standing Orders for Administering Human Papillomavirus Vaccine to Children and Teens ([link removed]) (additional update to font and QR code)
* Standing Orders for Administering Human Papillomavirus Vaccine to Adults ([link removed])
* Standing Orders for Administering Hepatitis A Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Hepatitis A Vaccine to Adults ([link removed])
* Standing Orders for Administering Varicella Vaccine to Children and Teens ([link removed])
* Standing Orders for Administering Varicella Vaccine to Adults ([link removed])
* Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Adults ([link removed])
* Standing Orders for Administering Pneumococcal Vaccines to Children and Teens ([link removed])
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates its "Notification of Immunization Letter Template"
Immunize.org updated its Notification of Immunization Letter Template ([link removed]) , adding Penmenvy (MenABCWY, GSK), which FDA licensed on February 14, 2025. ACIP voted on recommendations for its use at the April meeting; these recommendations are pending acceptance by the CDC Director or Secretary of Health and Human Services.
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
American Academy of Pediatrics releases four free on-demand Red Book webinars focused on measles
The American Academy of Pediatrics ([link removed]) released four free Red Book Online Webinars ([link removed]) focused on measles, including:
* Spotting a Threat: Measles in Immunocompromised Children (24:40)
* Infection Prevention & Control for Measles (14:56)
* The Use of Vitamin A in the Management of Measles (5:35)
* Identifying and Diagnosing Measles in the Pediatric Setting (two parts: 5:21, 9:44)
[link removed]
Earlier in 2025, the webinar series focused on “Mpox Basics.”
View the webinars ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Use CDC and Immunize.org’s resources to prepare travelers for domestic and international trips
To help with safe travel planning, use these three sets of travel resources.
Visit CDC's Travelers' Health ([link removed]) website to view information on more than 50 topics to help in deciding what vaccines, medications, and other measures are needed to prevent illness during travel.
[link removed]
CDC's Travelers' Health: Traveler Advice ([link removed]) web page includes information grouped by reasons for travel, travelers with special considerations, general tips, tips during travel, and tips after travel.
[link removed]
Immunize.org's Travel Vaccines main page ([link removed]) makes it easy to access current travel vaccination guidance from authoritative sources. It offers direct links to popular CDC and nongovernment resources.
The U.S. State Department allows travelers to register their itinerary and receive emergency messages via the Smart Traveler Enrollment Program ([link removed]) .
[link removed]
Related Links
* CDC: Travelers' Health ([link removed]) web page
* CDC: Travelers' Health: Traveler Advice ([link removed]) web page
* CDC Yellow Book: Health Information for International Travel ([link removed])
* Immunize.org: Travel Vaccines ([link removed]) main page
* U.S. Department of State: Smart Traveler Enrollment Program ([link removed])
Back to top (#Top)
------------------------------------------------------------
Keep the 2025 immunization schedule at your fingertips! Order laminated 2025 U.S. adult immunization schedule booklets from Immunize.org.
Laminated booklets of the 2025 U.S. adult immunization schedule ([link removed]) are available in the Immunize.org shop. The 2025 child and adolescent schedule booklets sold out.
The schedules are available online as PDFs from CDC ([link removed]) at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given.
[link removed]
Adult Booklets
1 copy: $10.00
2–4 copies: $9.50 each
5–19 copies: $8.50 each
20–99 copies: $7.50 each
100–499 copies: $6.00 each
500–999 copies: $5.00 each
1,000–1,999 copies: $4.00 each
2,000+ copies: $3.25 each
Visit the Shop Immunize.org: Laminated Schedules ([link removed]) web page to view images and order today!
For additional information, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Need to teach vaccine administration? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download
Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide ([link removed]) is available to download/print either by chapter or in its entirety free of charge. The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s Clinical Resources on adult immunization ([link removed])
Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“Measles in Pregnancy” published in Canadian Medical Association Journal
In the June 9 issue, the Canadian Medical Association Journal published Measles in Pregnancy ([link removed]) , a practice summary. The authors briefly explain five key points:
* Measles in pregnancy poses serious maternal and fetal risks
* Intravenous immunoglobulin (IVIG) can reduce the risk of infection or lessen the severity of measles during exposed, susceptible pregnancies
* Special care considerations are necessary for people admitted to hospital with measles, given its airborne transmission and high infectivity
* Maternal infection in the 2 weeks before delivery can lead to severe congenital infection
* Ensuring everyone of reproductive age is up to date with measles vaccination is crucial to prevent complications during pregnancy and after delivery
An accompanying editorial, Pregnant and Bearing the Burden of Measles Outbreaks in Canada ([link removed]) , points out:
Even in well-resourced settings, measles has devastating consequences. During an outbreak in Italy in 2017, researchers followed 24 pregnant women with measles infections, among whom were 6 (25.0%) premature deliveries; 4 (16.7%) miscarriages and fetal deaths; and 20 (80.0%) maternal hospitalizations from complications related to measles, most frequently pneumonia.
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today, virtual: NFID hosts webinar titled “Protecting Patients Before Travel” on June 18 at 1:00 p.m. (ET)
NFID ([link removed]) will host a webinar titled Protecting Patients Before Travel ([link removed] ) at 1:00 p.m. (ET) on June 18. The panel includes NFID Medical Director Robert H. Hopkins Jr., MD; Chapman University School of Pharmacy Professor Jeffery A. Goad, PharmD, MPH; and Harvard Medical School Associate Professor Lin H. Chen, MD. Speakers will review current recommendations for travelers and share implementation strategies.
CME and CNE credit are available. There is no fee to participate in this activity, but preregistration is required.
Register for the webinar ([link removed]) .
[link removed]
NFID hosts monthly webinars ([link removed]) to increase awareness of the importance of infectious disease prevention and treatment. CME, CNE, and CPE credits are available for select recordings. View all archived NFID webinars ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: Association of Immunization Managers hosts webinar titled “Correlation and Causation: Understanding and Debunking Claims Linking Vaccines and Autism” on June 24 at 2:00 p.m. (ET)
The Association of Immunization Managers (AIM) will host a webinar titled Correlation and Causation: Understanding and Debunking Claims Linking Vaccines and Autism ([link removed]) at 2:00 p.m. (ET) on June 24. Michelle Fiscus, MD, FAAP, AIM’s chief medical officer, will give an overview of autism spectrum disorder and how the vaccine-autism claim emerged and persists. Dr. Fiscus will summarize key studies that debunked the claim and share communication tools for immunization programs and healthcare providers to engage families and communities in informed conversations.
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: Public Health Communications Collaborative hosts webinar titled "Building Your Public Health Comms Toolkit: Communications Planning on a Budget" on June 25 at 3:30 p.m. (ET)
The Public Health Communications Collaborative (PHCC) will host a webinar titled Building Your Public Health Comms Toolkit: Communications Planning on a Budget ([link removed]) at 3:30 p.m. (ET) on June 25. During this webinar, public health and communications experts will provide tools, tips, and stories that support effective public health campaigns on small or nonexistent budgets. Attendees will learn more about:
* Building a free or low-cost toolkit for content planning, organization, and distribution of key public health messages
* How new partnership approaches can amplify your messages where people need to hear them
* Free or low-cost communication channels that can provide clarity, connection, and better community health outcomes
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: HPV Vaccine Acceleration Program Partners Initiative Consortium hosts webinar titled “Expanding Reach: Insights from Multi-Country Approaches to HPV Vaccination for Out-of-School Girls” on June 25 at 9:00 a.m. (ET)
The HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium ([link removed]) will host a webinar titled Expanding Reach: Insights from Multi-Country Approaches to HPV Vaccination for Out-of-School Girls ([link removed]) at 9:00 a.m. (ET) on June 25. During the webinar, learn how programs are reaching girls missed by school-based HPV vaccination efforts. The webinar will explore five themes: characterization of out-of-school girls; how programs identify such girls; program coordination; community awareness and demand generation; and delivery strategies.
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: Watch upcoming June 25–27 ACIP meeting with discussion of several vaccine recommendations, including COVID-19, HPV, influenza, meningococcal, and RSV
CDC is scheduled to convene the ACIP ([link removed]) on June 25–27. Recommendation votes are scheduled for COVID-19, HPV, influenza, meningococcal, and RSV vaccines. Additionally, the agenda includes discussion of vaccines targeting anthrax, chikungunya, cytomegalovirus (CMV), Lyme, and pneumococcal diseases.
After dismissing 17 members of ACIP ([link removed]) , HHS announced eight new members ([link removed]) .
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for written or oral public comment are described on the website ([link removed]) .
View meeting information ([link removed]) .
[link removed]
Related Links
* CDC: ACIP main page ([link removed]) for access to webcast, agendas
* CDC: ACIP: Meeting Information ([link removed]) for presentation slides, content from previous meetings, and information about future meetings
View the agenda ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: New Jersey Chapter of American Academy of Pediatrics hosts webinar, “From Inoculation to Innovation: The Historical and Ethical Journey of Vaccination,” on June 30 at 3:00 p.m. (ET)
The New Jersey Chapter of American Academy of Pediatrics (AAP) will host a webinar titled From Inoculation to Innovation: The Historical and Ethical Journey of Vaccination ([link removed] ) at 3:00 p.m. (ET) on June 30. The speakers will be David J. Cennimo, MD, FACP, Associate Professor of Medicine and Pediatric Infectious Disease, Rutgers University, and Luis Alzate-Duque, MD, MPH, Assistant Professor of Medicine and Pediatrics, Rutgers New Jersey Medical School. Learning objectives include:
* Exploring the historical milestones in vaccine development from early inoculation to modern immunization strategies
* Understanding the impact of vaccines on global health outcomes and economic savings, especially in childhood mortality and disease prevention
* Examining historical and ongoing opposition to vaccines, exploring the roots of vaccine hesitancy and organized anti-vaccination movements
* Discussing the ethical challenges related to vaccine mandates, informed consent, research practices, and global equity
* Evaluating the public health implications of vaccine acceptance and refusal, using predictive modeling and real-world case studies
Register for the webinar ([link removed] ) .
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Gr
äbenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp